SCHEMBL10242630

SCHEMBL10242630

CN(C)/C=C1\C(=O)CCNC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 5/20 0.37
POLB P06746 4/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
TP53 P04637 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAP2K1 Q02750 2/20 0.35
MAP1LC3B Q9GZQ8 6/20 0.35
HTT P42858 2/20 0.34
HIF1A Q16665 1/20 0.34
GAA P10253 2/20 0.33
LMNA P02545 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CRBN Q96SW2 1/20 0.33
RAF1 P04049 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6226055 1.00 MAPT (0.41) MAPTSMN1; SMN2ALDH1A1POLBMEN1
SCHEMBL6226053 1.00 MAPT (0.41) MAPTSMN1; SMN2ALDH1A1POLBMEN1
SCHEMBL27019949 0.77 POLB (0.41) MAPTSMN1; SMN2ALDH1A1POLBMEN1
SCHEMBL30008978 0.77 CRBN (0.38) MAPTSMN1; SMN2ALDH1A1POLBMEN1
SCHEMBL6837311 0.75 MAP1LC3B (0.47) MAPTSMN1; SMN2ALDH1A1POLBMEN1
SCHEMBL955853 0.72 SMN1; SMN2 (0.57) MAPTSMN1; SMN2ALDH1A1POLBMEN1
SCHEMBL3142596 0.72 SMN1; SMN2 (0.52) MAPTSMN1; SMN2ALDH1A1POLBMEN1
SCHEMBL21635879 0.70 SMN1; SMN2 (0.50) MAPTSMN1; SMN2ALDH1A1POLBMEN1
SCHEMBL116223 0.67
SCHEMBL24852911 0.65 MAP1LC3B (0.44) MAPTSMN1; SMN2ALDH1A1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2023-01-12 US disclosed
US-20230002374-A1 GPR52 MODULATOR COMPOUNDS NXERA PHARMA UK LIMITED (GB) 2023-01-05 US disclosed
US-20230002374-A1 GPR52 MODULATOR COMPOUNDS NXERA PHARMA UK LIMITED (GB) 2023-01-05 US disclosed
EP-4055016-A1 GPR52 MODULATOR COMPOUNDS Heptares Therapeutics Limited (GB) 2022-09-14 EP disclosed
CN-114650992-A GPR52 modulator compounds 赫普泰雅治疗有限公司 2022-06-21 CN disclosed
US-20210147427-A1 PYRAZOLO-TRIAZINE AND/OR PYRAZOLO-PYRIMIDINE DERIVATIVES AS SELECTIVE INHIBITOR OF CYCLIN DEPENDENT KINASE LEAD DISCOVERY CENTER GMBH (DE) 2021-05-20 US disclosed
US-10745401-B2 Condensed lactam derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-18 US disclosed
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-13 US disclosed
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-06-04 US disclosed
WO-2020022237-A1 FUSED RING LACTAM DERIVATIVES 大日本住友製薬株式会社 2020-01-30 WO disclosed
WO-2020022237-A1 FUSED RING LACTAM DERIVATIVES 大日本住友製薬株式会社 2020-01-30 WO disclosed
US-9504251-B2 Pesticidal compositions and related methods DOW AGROSCIENCES LLC (US) 2016-11-29 US disclosed
US-20150327551-A1 PESTICIDAL COMPOSITIONS AND RELATED METHODS CORTEVA AGRISCIENCE LLC 2015-11-19 US disclosed
WO-2015175719-A1 PESTICIDAL COMPOSITIONS AND RELATED METHODS DOW AGROSCIENCES LLC (US) 2015-11-19 WO disclosed
WO-2012085167-A1 METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002374-A1 GPR52 MODULATOR COMPOUNDS GPR52, GPR119, GPR4 MAPT 3912/4885SMN1; SMN2 2536/4885ALDH1A1 1435/4885
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE PSEN1, GRIN1, HDAC1 MAPT 38/4885SMN1; SMN2 280/4885ALDH1A1 858/4885
US-20150327551-A1 PESTICIDAL COMPOSITIONS AND RELATED METHODS ACHE, MYH9, UNC119 MAPT 4488/4885SMN1; SMN2 2192/4885ALDH1A1 1561/4885
US-10745401-B2 Condensed lactam derivative PSEN1, GRIN1, HDAC1 MAPT 38/4885SMN1; SMN2 280/4885ALDH1A1 858/4885
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 MAPT 720/4885SMN1; SMN2 1775/4885ALDH1A1 973/4885
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE PSEN1, GRIN1, HDAC1 MAPT 38/4885SMN1; SMN2 280/4885ALDH1A1 858/4885
US-20210147427-A1 PYRAZOLO-TRIAZINE AND/OR PYRAZOLO-PYRIMIDINE DERIVATIVES AS SELECTIVE INHIBITOR OF CYCLIN DEPENDENT KINASE CDK1, CDK2, CDK15 MAPT 3370/4885SMN1; SMN2 4011/4885ALDH1A1 1986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.